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The determination of nutritional requirements of pathogenic organisms is of great significance for understanding host-
pathogen interactions. Despite the knowledge obtained so far concerning amino acid requirements in H. pylori, it is still 
unclear which are the metabolic pathways used for biosynthesis and catabolism. Thus, information on the carbon flow 
in this organism is required. Glutamate is a very important metabolite in bacterial metabolism that can be used as a 
carbon and nitrogen source. 13C flux analysis has been largely applied to characterize phenotypes by quantifying in 
vivo the carbon fluxes. One of the most important applications of this approach is the identification of active pathways 
in less-studied organisms. Thus, in order to clarify the metabolic pathways used by H. pylori 26695, 13C labeling 
experiments with 13C-glutamate were conducted and labeled amino acids in biomass hydrolysates were analyzed by 
GC-MS. The obtained results confirmed L-glutamate as a potential sole and effective carbon source for H. pylori. 
Overall, all non-essential amino acids, except proline, presented a 13C labeling pattern. We hypothesized that L-proline 
is produced from L-arginine, while L-alanine is probably produced from pyruvate by alanine dehydrogenase. 
Additionally, the full usage of complete TCA cycle, under the conditions used, was also demonstrated. 
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Dysfunction of the mitochondrial respiratory chain causes a variety of disorders affecting particularly organs with high 
metabolic demands, such as brain, heart and liver. The causative pathogenic mutations reduce the activity of 
mitochondrial respiratory complexes, leading to decreased ATP production, and accumulation of lipids, TCA cycle 
intermediates, lactic acid, and some amino acids. The severity and tissue specificity of the disorders varies between 
patients by unknown mechanisms, and treatments are limited to compensating for dysfunctional metabolism, and 
stabilising complexes by dietary supplements of antioxidants, riboflavin and bicarbonate. To better understand how 
respiratory chain dysfunction impacts metabolism and how metabolites may have compensatory or deleterious effects, 
we simulated deficiencies of the mitochondrial respiratory complexes using computer models of metabolic networks. 
Our simulations show complex III and IV deficiencies cause greatest decreases in ATP production. But - depending on 
which complex is deficient - ATP production can be increased by supplying amino acids, including glutamate, 
aspartate, arginine and proline. Simulations of complex I disorders show various pathways can compensate the 
underlying deficiency. Conversely, little compensates for complex II deficiencies. Overall, our simulations are 
consistent with patient phenotypes, supporting their biological significance and demonstrating how computer modelling 
can further understanding and treatment of mitochondrial disorders.  
